Two additional studies involving 200 NSCLC patients have shown that changes in the level of IL-8 along with the chemokine CXCL10 can serve as a prognostic indicator of response to ICI (Table 3). This evidence concerns the gene CXCL8 and non-small cell lung carcinoma.